[Pharmacological aspects of fibrinolysis]. 1969

G Prino, and M Mantovani

UI MeSH Term Description Entries
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin

Related Publications

G Prino, and M Mantovani
May 1971, La Clinica terapeutica,
G Prino, and M Mantovani
January 1972, Acta Universitatis Carolinae. Medica. Monographia,
G Prino, and M Mantovani
October 1969, Bristol medico-chirurgical journal (1963),
G Prino, and M Mantovani
May 1969, Journal of clinical pathology,
G Prino, and M Mantovani
July 1964, Lancet (London, England),
G Prino, and M Mantovani
February 1965, Klinische Wochenschrift,
G Prino, and M Mantovani
December 1959, Casopis lekaru ceskych,
G Prino, and M Mantovani
March 1964, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
G Prino, and M Mantovani
January 1981, Annals of the New York Academy of Sciences,
G Prino, and M Mantovani
January 2014, Kardiologiia,
Copied contents to your clipboard!